-
公开(公告)号:US20220153709A1
公开(公告)日:2022-05-19
申请号:US17590503
申请日:2022-02-01
申请人: The George Washington University, A Congressionally Chartered Not-for-Profit Corporation , The Board of Trustees of the University of Illinois
IPC分类号: C07D261/18 , A61P35/00 , C07D413/06 , C07D417/06 , C07D471/04
摘要: The present disclosure provides compounds represented by Formula I: and pharmaceutically acceptable salts, solvates, e.g., hydrates, and prodrugs thereof, wherein X and n are as defined as set forth in the specification. The present disclosure also provides compounds of Formula I for use to treat diseases and conditions, e.g., cancer, wherein inhibition of HDAC provides a benefit.
-
公开(公告)号:US20240343697A1
公开(公告)日:2024-10-17
申请号:US18618511
申请日:2024-03-27
申请人: The George Washington University, A Congressionally Chartered Not-for-Profit Corporation , The Board of Trustees of the University of Illinois
IPC分类号: C07D261/18 , A61K45/06 , A61P35/00 , C07D413/06 , C07D417/06 , C07D471/04
CPC分类号: C07D261/18 , A61P35/00 , C07D413/06 , C07D417/06 , C07D471/04 , A61K45/06
摘要: The present disclosure provides compounds represented by Formula I:
and pharmaceutically acceptable salts, solvates, e.g., hydrates, and prodrugs thereof, wherein X and n are as defined as set forth in the specification. The present disclosure also provides compounds of Formula I for use to treat diseases and conditions, e.g., cancer, wherein inhibition of HDAC provides a benefit.
-